Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Cardiovascular Agents
  • Chemotherapy, Adjuvant
  • Myocardial Infarction
  • Peptides
  • Protein Kinase C-delta
  • Protein Kinase Inhibitors

abstract

  • KAI-9803 had an acceptable safety and tolerability profile when delivered via intracoronary injection during primary percutaneous coronary intervention for ST-segment elevation MI. Signs of potential drug activity were demonstrated with biomarker end points in this small exploratory study, indicating that further testing of KAI-9803 as an adjunctive therapy for ST-segment elevation MI is warranted.

publication date

  • February 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.107.759167

PubMed ID

  • 18250271

Additional Document Info

start page

  • 886

end page

  • 96

volume

  • 117

number

  • 7